Athenex Inc (ATNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATNX | AMGN | GILD | CELG | ILMN |
| Company | Athenex Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.2200 | 339.00 | 84.25 | 108.01 | 131.15 |
| High | 0.2571 | 339.17 | 84.46 | 108.59 | 131.38 |
| Low | 0.2016 | 333.36 | 83.48 | 107.27 | 128.38 |
| Last | 0.2031 | 335.61 | 83.99 | 108.24 | 130.10 |
| Change | -0.0620 | -1.77 | +0.05 | +0.11 | -1.10 |
| % Change | -23.39% | -0.52% | +0.06% | +0.10% | -0.84% |
| Volume | 1,880,200 | 1,653,493 | 6,248,325 | 191,230,496 | 2,148,688 |
| 20-Day Average Volume | 532,720 | 1,816,965 | 7,539,623 | 16,188,930 | 1,455,876 |
| Previous Close | 0.2651 | 337.38 | 83.94 | 108.13 | 131.20 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9093 | 330.57 | 80.84 | 108.17 | 129.23 |
| 20-Day Raw Stochastic | 0.12% | 82.25% | 89.26% | 63.25% | 61.48% |
| 20-Day Relative Strength | 22.55% | 56.83% | 72.04% | 64.69% | 54.57% |
| Weighted Alpha | -90.12 | +26.19 | +18.25 | +46.30 | +1.30 |
| Today's Opinion | 100% Sell | 100% Buy | 88% Buy | 100% Buy | 72% Buy |
| Previous Opinion | 100% Sell | 100% Buy | 88% Buy | 100% Buy | 72% Buy |
| Last Month's Opinion | 100% Sell | 72% Buy | 72% Buy | 100% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -42.15% since 05/17/23 | +0.10% since 09/16/24 | +0.99% since 09/16/24 | -1.97% since 11/13/19 | +0.49% since 09/16/24 |
| Low | 0.2016 on 05/24/23 | 331.00 on 09/18/24 | 82.38 on 09/17/24 | 107.27 on 11/20/19 | 128.38 on 09/23/24 |
| High | 0.3830 on 05/19/23 | 339.17 on 09/23/24 | 84.65 on 09/19/24 | 110.53 on 11/14/19 | 136.19 on 09/19/24 |
| 1-Month | |||||
| %Chg | -83.75% since 04/24/23 | +2.07% since 08/23/24 | +9.46% since 08/23/24 | +5.14% since 10/18/19 | -0.94% since 08/23/24 |
| Low | 0.2016 on 05/24/23 | 319.00 on 09/06/24 | 76.42 on 08/26/24 | 102.40 on 10/21/19 | 120.51 on 09/12/24 |
| High | 1.4699 on 05/03/23 | 339.17 on 09/23/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 136.19 on 09/19/24 |
| 3-Month | |||||
| %Chg | -92.59% since 02/24/23 | +8.90% since 06/21/24 | +18.83% since 06/21/24 | +13.63% since 08/20/19 | +19.88% since 06/21/24 |
| Low | 0.2016 on 05/24/23 | 306.11 on 07/03/24 | 66.01 on 07/05/24 | 93.41 on 08/23/19 | 103.52 on 06/28/24 |
| High | 2.9800 on 03/06/23 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 137.18 on 08/20/24 |
| 6-Month | |||||
| %Chg | -94.12% since 11/23/22 | +21.52% since 03/22/24 | +15.66% since 03/22/24 | +14.14% since 05/20/19 | -5.17% since 03/22/24 |
| Low | 0.2016 on 05/24/23 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 100.08 on 05/30/24 |
| High | 6.0000 on 12/20/22 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 140.07 on 03/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,759 | 180,982,432 | 104,576,912 | 77,035,920 | 20,900,160 |
| Shares Outstanding, K | 8,663 | 536,435 | 1,245,853 | 711,714 | 159,300 |
| Annual Sales | 102,820,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -103,430,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 8,050,000 | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 1,112,000,000 |
| Last Quarter Net Income | -34,180,000 | 746,000,000 | 1,614,000,000 | 1,691,000,000 | -1,988,000,000 |
| 60-Month Beta | 1.36 | 0.61 | 0.18 | 1.41 | 1.15 |
| Per-Share Information | |||||
| Most Recent Earnings | -3.38 on 03/20/23 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | 0.36 on 08/06/24 |
| Latest Earnings Date | 05/30/23 | 10/29/24 | 11/05/24 | 10/31/19 | 11/14/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.06 | 17.85 | 10.99 | 146.08 |